Lower Respiratory Disorders Flashcards
Pulmonary Embolism (PE)
Emboli; mobile clots that travel through circulatory system
Blockage in a pulmonary artery by an embolic thrombus (fat or air embolus, or tissue from a tumor)
Travel to ever-smaller blood vessels until it lodges & obstructs perfusion of the alveoli
More than 90% arise from deep vein thrombosis (DVT) of the legs
Usually affects lower lobes d/t high volume of blood flow
10% of patients die within the first hour
Treatment with anticoagulants reduces mortality to less than 5%
PE Risk Factors
Immobility or reduced mobility
Surgery in the last 3 months
History of DVT
Malignancy
Obesity
Oral contraceptives & hormone therapy
Heavy cigarette smoking
Prolonged air travel
Heart failure
Pregnancy
Clotting disorders
PE Clinical Manifestations
Varied & nonspecific, making it difficulty to diagnose
Dyspnea
Hypoxemia (if severe, change in mental status)
Tachypnea
Cough
Chest pain
Hemoptysis
Crackles and/or wheezing
Tachycardia
Fever
Syncope
Massive PE = hypotension & shock
Complications
Pulmonary Infarction
Death of lung tissue
May become infected & abscess may develop
Pulmonary Hypertension
from a massive or recurrent PE
Results from hypoxemia or damage to 50% of area’s normal pulmonary bed
PE Diagnostic Studies
Find under-lying cause; DVT or AFIB?)
Spiral (helical) CT scan w/ IV contrast
Most frequently used to diagnose PE
Ventilation-perfusion (V/Q) lung scan
Used for those allergic to IV contrast
Mismatch of perfusion & ventilation indicates PE
EKG monitoring
Labs:
CBC
BMP
ABG’s
PTT
PT / INR
Troponin
D-dimer
Measures fibrin fragments
Not always accurate
Chest X-Ray
Venous ultrasound
Pulmonary angiography
PE Collaborative Care
Immediate treatment as soon as PE suspected
Bedrest; Semi-Fowler’s position
02 by NC or mask
Cardiac monitoring, VS, 02 level, ABG’s, breath sounds
Fibrinolytic agent
IV Heparin drip (RN management by protocol)
Lovenox (Low-molecular-weight Heparin)
Warfarin (Coumadin)
Monitor PTT and/or PT/INR levels
Opioids for pain relief
Medications PRN anxiety
Inferior Vena Cava filter
Inserted via femoral vein, placed at level of diaphragm
Pulmonary embolectomy
Patient Teaching
Risk factors
Long-term anticoagulant therapy
Frequent blood draws for PT/INR monitoring
Coumadin adjustments
Dietary considerations
Pneumonia
Acute infection of lung parenchyma
Gram-negative bacilli
8th leading cause of death in 2018
Impacted by discovery of Sulfa & Penicillin
Despite new anti-microbial agents, morbidity & mortality still significant
Risk Factors
Immunosuppressive diseases or debilitating illness
Increased risk of aspiration
Decreased cough & epiglottal reflexes, tube feedings
Impaired muco-ciliary mechanism
Pollution
Smoking
Upper respiratory infections
Tracheal intubation
Age >65 years
Malnutrition
Inhalation of microbes (Mycoplasma/fungus)
Spread from primary infection elsewhere in body
Opportunistic Pneumonia
Altered immune system
Severe protein-calorie malnutrition
HIV / AIDS
Radiation therapy
Chemotherapy
Long-term corticosteroid therapy
Pneumocystis jiroveci (fungus)– needs a human host
Cytomegalovirus (CMV)
Community-Acquired Pneumonia (CAP)
7th leading cause of death for those over 65 years old
Pre-hospital onset or within first 2-days of admit
Highest incidence in winter
Smoking important risk factor
May present only with dyspnea & fever while lung tissue is necrotized
Viral manifestations vary:
Fever, chills
Dry, non-productive cough
Extra-pulmonary symptoms
Hospital-Acquired Pneumonia (HAP)
48-hours or more after admission
Early (5-days or less post admission)
Late (more than 5-days post admission)
Nosocomial infection with highest mortality
Pseudomonas
Enterobacter
S. Aureus
S. Pneumoniae
Risk factors:
Immunosuppression
General debility
ET Tube (VAP)
Fungal/aspiration pneumonia
Loss of consciousness
Gag/cough reflexes
Tube feedings
CAP
Gradual symptom onset
Dry cough
Headache
Malaise / fatigue
Sore throat
N/V/D (S. aureus)
HAP
Sudden onset symptoms
Fever
Chills
Productive cough
Purulent sputum
Pleuritic chest pain
Confusion or stupor in older or debilitated patient
Clinical Manifestations CAP/HAP
Cough – non-productive or productive – green, yellow, bloody
Fever/chills/shaking
Dyspnea
Tachypnea
Pleuritic chest pain
May initially appear as influenza, then respiratory sypmtoms
Confusion or stupor r/t hypoxia
Hypothermia (in elderly)
Diaphoresis, anorexia, fatigue, myalgia, headache, abd pain
Rhonchi and Crackles
Dullness to percussion over affected area
Diagnostic Studies CAP/HAP
H & P
Chest X-Ray
Vital Signs - Sp02 and ABG’s
CBC, CMP, Blood Cultures
Sputum Culture – prior to Antibiotic therapy
Collaborative Therapy
CAP/HAP
Antibiotic therapy: Multi-drug resistant pneumonia is a major problem
Increased fluid intake (3L/day)
Limit activity and rest
Antipyretics
Analgesics
02 therapy
Influenza & Pneumonia Vaccination - pneumovax
Complications from Pneumonia
Pleurisy or pleural effusion
Atelectasis
Persistent infection
Lung abscess
Empyema
Pericarditis
Endocarditis
Arthritis
Meningitis
Pneumothorax
Sepsis
Respiratory failure